"These results are stunning." The post Scientists Identify Possible Game Changing Treatment for Alzheimer’s Disease That ...

"Neumora’s Alzheimer’s disease agitation drug shows early success in Phase Ib trial" was originally created and published by ...

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...

Summary: Researchers have created a new experimental model that reveals how changing a key Alzheimer’s risk gene can shift ...

Two new groundbreaking drugs could slow the memory impairment, thinking skills and overall brain decline — and both are ...

U.S. pharmaceutical company Eli Lilly plans to disclose the topline results of its phase 3 clinical trial for “remternutux,” a new drug candidate developed as a successor to its Alzheimer’s treatment ...

You think you’re fine. Your family and friends think you’re fine. But, just maybe, you’re not. Maybe you already have Alzheimer’s disease, but you just don’t know it yet, because it can begin ...

Sharon Runge has become the first patient in Canadian history to receive an infusion of an Alzheimer’s drug recently approved ...

Age remains the greatest risk factor for Alzheimer's. However, research has shown that early-onset of the disease has also ...

Discovery could redirect drug development for disease affecting 6.7 million Americans The two AMPKα isoforms can have ...

Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), ...